RL Group DBA Reinvent Life Treatment Centers

RL Group DBA Reinvent Life Treatment Centers is a SAMHSA-registered addiction-treatment facility in Chicago, IL. The facility's programming is outpatient (Outpatient), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at RL Group DBA Reinvent Life Treatment Centers

On care levels: RL Group DBA Reinvent Life Treatment Centers is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

RL Group DBA Reinvent Life Treatment Centers accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The operational prerequisite is written documentation: in-network status for your specific plan product, deductible accumulation, coinsurance rate, prior-authorization status. Admissions without these four documented carry material risk of post-admission financial disagreement.

Before you call

The operational due diligence on RL Group DBA Reinvent Life Treatment Centers comes down to three documents: ASAM-aligned level-of-care documentation matching independent clinical assessment, written Verification of Benefits for your specific plan product, written MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether RL Group DBA Reinvent Life Treatment Centers offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.